Chugai Pharmaceutical Co (CUP) Revenue
Chugai Pharmaceutical Co Revenue
Chugai Pharmaceutical Co had a revenue of 404.74B in the quarter ending Sep 30, 2026, with 18.49%. This bring the company's revenue in the last twelve months to 1.41T, Increased 5.33%. In the fiscal year ending Dec 31, 2025, Chugai Pharmaceutical Co had annual revenue of 1.26T with 7.46% growth.
- Revenue (ttm)
- 1.41T
- Revenue Growth
- 5.11%
- P/S Ratio
- 0.05
- Revenue/Employee
- EUR 246,461,795
- Employees
- 5,104
- Market Cap
- EUR 63.59B
Revenue Chart
Chugai Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.26T | 87.33B | 7.46% |
| Dec 31, 2024 | 1.17T | 59.24B | 5.33% |
| Dec 31, 2023 | 1.11T | -148.58B | -11.79% |
| Dec 31, 2022 | 1.26T | 260.19B | 26.03% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | 686.18B | 106.40B | 18.35% |
| Dec 31, 2018 | 579.79B | 45.59B | 8.53% |
| Dec 31, 2017 | 534.20B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.